載入...
Long-term response of over ten years with sorafenib monotherapy in metastatic renal cell carcinoma: a case report
BACKGROUND: Molecular targeted therapies have dramatically improved the prognosis of metastatic renal cell carcinoma. However, patients in whom the treatment could initially be effective will experience disease progression later. CASE PRESENTATION: A 74-year-old Japanese man who was diagnosed with r...
Na minha lista:
| 發表在: | J Med Case Rep |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4911686/ https://ncbi.nlm.nih.gov/pubmed/27312478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-016-0961-0 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|